[ Price : $8.95]
Abivax announces new Phase 3 data showing that its lead drug candidate, obefazimod, achieved clinically meaningful improvements ac...[ Price : $8.95]
FDA approves an Arcutis Biotherapeutics supplemental NDA for Zoryve (roflumilast) cream 0.05% for treating mild to moderate atopic...[ Price : $8.95]
FDA unveils a new pilot program to prioritize the review of certain generic drug ANDAs in an effort to boost domestic pharmaceutic...[ Price : $8.95]
FDA commissioner Marty Makary talks with CNNs Sanjay Gupta and says he wants to speed up the nations drug approval process without...[ Price : $8.95]
A new Brookings Institution commentary raises concerns about FDAs new Commissioners National Priority Voucher pilot program.[ Price : $8.95]
FDA approves the second generic copy of abortifacient mifepristone, a move that prompted mixed reactions from lawmakers and advoca...[ Price : $8.95]
FDA posts a five-item FDA Form-483 after inspecting Covid-19 vaccine maker Serum Institute of Indias Maharashtra manufacturing fac...[ Price : $8.95]
Rocket Pharmaceuticals withdraws its BLA for RP-L102 (mozafancogene autotemcel), an investigational gene therapy for treating Fanc...